Close Menu

NEW YORK – Chinese infectious disease startup Visions Medical said on Thursday it recently closed a Series B financing round that raised RMB200 million ($28.8 million).

The round was led by CDH Investments with contributions from CICC Capital, the Guangzhou-based firm said. So far, Visions Medical has raised nearly $50 million, including a $14 million Series A round last year. 

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

SARS-CoV-2 vaccine developers are evaluating further vaccine doses as well as modified doses to keep up with new viral variants, according to CNN.

The New York Times reports that a new viral variant of concern has been identified in New York City.

In Nature this week: spatiotemporally resolved map of the human cell cycle, folding single-cell RNA sequencing into cancer drug studies, and more.

According to BBC News, the global vaccine-sharing initiative has sent its first shipment, which arrived in Ghana this week.